Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score "Fetal gRowth AbnorMality dEtection Trial" 09/14/2021 INTERVENTIONAL unchanged 1,807.85 0 A Study to Evaluate the Efficacy and Safety of CYH33 in Patients With Recurrent/Persistent Ovary Clear Cell Carcinoma 09/14/2021 INTERVENTIONAL unchanged 1,807.85 0 Kuwa Free! - Live Free! 09/16/2021 INTERVENTIONAL unchanged 1,805.85 0 Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix 09/16/2021 OBSERVATIONAL unchanged 1,805.85 0 Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications 09/16/2021 OBSERVATIONAL unchanged 1,805.85 0 Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant 09/16/2021 OBSERVATIONAL unchanged 1,805.85 0 Determine the Utility of Liquid Biopsies and Tumor Molecular Profiling in Predicting Recurrence in Endometrial Cancers 09/20/2021 OBSERVATIONAL unchanged 1,801.85 0 Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy 09/20/2021 INTERVENTIONAL unchanged 1,801.85 0 Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer 09/21/2021 OBSERVATIONAL unchanged 1,800.85 0 Inspiring New Science In Guiding Healthcare in Turner Syndrome Registry 09/22/2021 OBSERVATIONAL unchanged 1,799.85 0 Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women 09/22/2021 INTERVENTIONAL unchanged 1,799.85 0 Identification of Breast Cancer Specific Markers in Patients Compared to Healthy Participants 09/23/2021 OBSERVATIONAL unchanged 1,798.85 0 Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work 09/24/2021 INTERVENTIONAL unchanged 1,797.85 0 Incentive Processing and Learning in Anorexia Nervosa and Bulimia Nervosa 09/24/2021 OBSERVATIONAL unchanged 1,797.85 0 Prediction of Chronic Kidney Disease Following Pre-eclampsia: Diagnosis and Early Care 09/24/2021 INTERVENTIONAL unchanged 1,797.85 0 Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics 09/27/2021 OBSERVATIONAL unchanged 1,794.85 0 Contrast Enhanced Spectral Mammography for the Evaluation of Pathologic Nipple Discharge 09/27/2021 INTERVENTIONAL unchanged 1,794.85 0 Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen 09/27/2021 OBSERVATIONAL unchanged 1,794.85 0 Ovarian Hormone Regulation of Central and Cerebrovascular Hemodynamics (NoMEN Study) 09/27/2021 INTERVENTIONAL unchanged 1,794.85 0 DianaWeb: Before and After Study Online Based Participatory Research on Breast Cancer Women 09/27/2021 INTERVENTIONAL unchanged 1,794.85 0 Contraceptive Hormone and Reward Measurement (CHARM Study) 09/28/2021 INTERVENTIONAL unchanged 1,793.85 0 Romosozumab Use to Build Skeletal Integrity 09/28/2021 INTERVENTIONAL unchanged 1,793.85 0 Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast Cancer 09/28/2021 INTERVENTIONAL unchanged 1,793.85 0 Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer 09/30/2021 INTERVENTIONAL unchanged 1,791.85 0 Patient-Centered Outcomes in the Surgical Treatment of Uterovaginal Prolapse 10/01/2021 INTERVENTIONAL unchanged 1,790.85 0 The Roles of Gut Microbiome in UTI Susceptible Women 10/01/2021 INTERVENTIONAL unchanged 1,790.85 0 Psilocybin-facilitated Treatment for Chronic Pain 10/06/2021 INTERVENTIONAL unchanged 1,785.85 0 Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy 10/06/2021 INTERVENTIONAL unchanged 1,785.85 0 Endometriosis and Microvascular Dysfunction: Role of Inflammation 10/06/2021 INTERVENTIONAL unchanged 1,785.85 0 SBRT in Early Breast Cancer in Elderly Women 10/07/2021 INTERVENTIONAL unchanged 1,784.85 0 ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer 10/08/2021 INTERVENTIONAL unchanged 1,783.85 0 A Study of Near-Infrared Fluorescence Imaging With ICG During Reconstructive Gynecologic Surgery 10/08/2021 INTERVENTIONAL unchanged 1,783.85 0 Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial 10/08/2021 INTERVENTIONAL unchanged 1,783.85 0 The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer 10/12/2021 INTERVENTIONAL unchanged 1,779.85 0 Reverse Triple Negative Immune Resistant Breast Cancer 10/13/2021 INTERVENTIONAL unchanged 1,778.85 0 Groningen International Study on Sentinel Nodes in Vulvar Cancer-III 10/13/2021 INTERVENTIONAL unchanged 1,778.85 0 A Study of XZP-3287 in Combination With Fulvestrant in Patients With Advanced Breast Cancer 10/14/2021 INTERVENTIONAL unchanged 1,777.85 0 Mechanisms, Predictors, and Social Determinants of Cardiotoxicity in Breast Cancer 10/14/2021 OBSERVATIONAL unchanged 1,777.85 0 Low-cost Imaging Technology for Global Prevention of Cervical Cancer 10/14/2021 INTERVENTIONAL unchanged 1,777.85 0 Comparative Performance of a Vaginal Yeast Test 10/15/2021 OBSERVATIONAL unchanged 1,776.85 0 Bacterial Cellulose-monolaurin Hydrogel for Acute Radiation Dermatitis 10/15/2021 INTERVENTIONAL unchanged 1,776.85 0 The Stimulation To Induce Mothers Study 10/15/2021 INTERVENTIONAL unchanged 1,776.85 0 Effect of Oral Carbohydrate Intake > 44kCal Per Hour During Labour on the Rate of Instrumental Vaginal Delivery 10/15/2021 INTERVENTIONAL unchanged 1,776.85 0 Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer 10/15/2021 INTERVENTIONAL unchanged 1,776.85 0 Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment 10/15/2021 INTERVENTIONAL unchanged 1,776.85 0 Using Aspirin to Improve Immunological Features of Ovarian Tumors 10/18/2021 INTERVENTIONAL unchanged 1,773.85 0 Integrated Hyperglycaemia Incentivised Postnatal Surveillance Study (I-HIPS) 10/18/2021 INTERVENTIONAL unchanged 1,773.85 0 Glucose Homeostasis, Metabolomics and Pregnancy Outcomes After Bariatric Surgery 10/19/2021 OBSERVATIONAL unchanged 1,772.85 0 The Efficacy of Auto-cross Linked Hyaluronic Acid Gel in the Prevention of Adhesion Reformation After Hysteroscopic Resection of Retained Products of Conception 10/20/2021 INTERVENTIONAL unchanged 1,771.85 0 Virtual and Video Counseling Versus In-Office Counseling for Laparoscopic Hysterectomy 10/20/2021 INTERVENTIONAL unchanged 1,771.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology